-
The Flagship Antibody-Drug Conjugate Event is Back! – World ADC Asia 2024
26 Apr 2024 07:03 GMT
… thing when it comes to antibody-drug conjugate development. The 3rd … Capabilities & the Challenges With Antibody & Linker-Payload Supply Chain … in the region and accelerating antibody-drug conjugates to approval. World …
-
Modernizing the Purification Toolbox for Multi-specific Antibodies, CRISPR and Cell and Gene Therapies"' data-event="clickContentCardButton" data-contentid="385838" data-contenttype="Webinar"…
26 Apr 2024 01:14 GMT
… Purification Toolbox for Multi-specific antibodies, CRISPR and Cell and Gene …
-
Optimizing Bispecific Antibodies in Multiple Myeloma for Efficacy, Safety
25 Apr 2024 23:40 GMT
Bispecific antibodies are revolutionizing the treatment of … the efficacy of similar bispecific antibodies in earlier lines of treatment …
-
Stress impact on protein particle formation for monoclonal antibody formulation
25 Apr 2024 22:36 GMT
… on an “industrially relevant [immunoglobulin G] (IgG) [monoclonal antibody] (mAb) solution.” Formation …
-
Nektar exercises TNFR2 antibody option from Biolojic collaboration
25 Apr 2024 16:19 GMT
-
Antibody Testing for Isoniazid and Rifapentine in Treatment of Latent Tuberculosis Infection
24 Apr 2024 23:26 GMT
… investigating associations between anti-rifampin antibodies and flu-like reactions … controls.
Investigators concluded that although antibodies against rifapentine, isoniazid, and … suggesting these reactions were not antibody-mediated.
Source: academic.oup. …
-
Shanghai De Novo Pharmatech discovers new antibody-immunostimulatory conjugates
24 Apr 2024 18:23 GMT
-
Oncoc4 to advance anti-Siglec-10 antibody into clinic
24 Apr 2024 18:23 GMT
-
BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design
24 Apr 2024 16:00 GMT
… and selection of high-quality antibodies for multiple Neuroscience therapeutic targets … full-stack antibody discovery and engineering platform, to engineer antibodies with more … reduces the difficulty of designing antibodies and other therapeutic proteins to …
-
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
24 Apr 2024 14:09 GMT
… , potential first-in-class antibody that binds to MICA and … (anti-MICA/B antibody) alone and in combination with … in-class humanized IgG1 monoclonal antibody that binds to the … immune activation, and by inducing antibody-dependent cellular toxicity (ADCC) …